Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 279 citing articles:

The ORF8 protein of SARS-CoV-2 mediates immune evasion through down-regulating MHC-Ι
Yiwen Zhang, Yingshi Chen, Yuzhuang Li, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 23
Open Access | Times Cited: 390
A Comprehensive Review of the Global Efforts on COVID-19 Vaccine Development
Yingzhu Li, Rumiana Tenchov, Jeffrey Smoot, et al.
ACS Central Science (2021) Vol. 7, Iss. 4, pp. 512-533
Open Access | Times Cited: 316
Vaccine adjuvants: mechanisms and platforms
Tingmei Zhao, Yulong Cai, Yujie Jiang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 285
Neutralizing antibody vaccine for pandemic and pre-emergent coronaviruses
Kevin O. Saunders, Esther Lee, Robert Parks, et al.
Nature (2021) Vol. 594, Iss. 7864, pp. 553-559
Open Access | Times Cited: 235
SARS-CoV-2 Vaccines Based on the Spike Glycoprotein and Implications of New Viral Variants
Daniel Martínez-Flores, Jesús Zepeda–Cervantes, Adolfo Cruz-Reséndiz, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 211
Mosaic RBD nanoparticles protect against challenge by diverse sarbecoviruses in animal models
Alexander A. Cohen, Neeltje van Doremalen, Allison J. Greaney, et al.
Science (2022) Vol. 377, Iss. 6606
Open Access | Times Cited: 188
Two-component spike nanoparticle vaccine protects macaques from SARS-CoV-2 infection
Philip J. M. Brouwer, Mitch Brinkkemper, Pauline Maisonnasse, et al.
Cell (2021) Vol. 184, Iss. 5, pp. 1188-1200.e19
Open Access | Times Cited: 181
Scientific rationale for developing potent RBD-based vaccines targeting COVID-19
Harry Kleanthous, Judith M. Silverman, Karen W. Makar, et al.
npj Vaccines (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 136
Broad neutralization of SARS-CoV-2 variants by an inhalable bispecific single-domain antibody
Cheng Li, Wuqiang Zhan, Zhenlin Yang, et al.
Cell (2022) Vol. 185, Iss. 8, pp. 1389-1401.e18
Open Access | Times Cited: 131
Nanomedicine for acute respiratory distress syndrome: The latest application, targeting strategy, and rational design
Qi Qiao, Xiong Liu, Ting Yang, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 11, Iss. 10, pp. 3060-3091
Open Access | Times Cited: 120
Animal Models for COVID-19: Hamsters, Mouse, Ferret, Mink, Tree Shrew, and Non-human Primates
Shuyu Shou, Menghui Liu, Yang Yang, et al.
Frontiers in Microbiology (2021) Vol. 12
Open Access | Times Cited: 108
Single-component, self-assembling, protein nanoparticles presenting the receptor binding domain and stabilized spike as SARS-CoV-2 vaccine candidates
Linling He, Xiaohe Lin, Ying Wang, et al.
Science Advances (2021) Vol. 7, Iss. 12
Open Access | Times Cited: 103
SARS-CoV-2 S2–targeted vaccination elicits broadly neutralizing antibodies
Kevin W. Ng, Nikhil Faulkner, Katja Finsterbusch, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 655
Open Access | Times Cited: 84
A novel STING agonist-adjuvanted pan-sarbecovirus vaccine elicits potent and durable neutralizing antibody and T cell responses in mice, rabbits and NHPs
Zezhong Liu, Jie Zhou, Wei Xu, et al.
Cell Research (2022) Vol. 32, Iss. 3, pp. 269-287
Open Access | Times Cited: 71
mRNA Vaccines Against SARS‐CoV‐2 Variants Delivered by Lipid Nanoparticles Based on Novel Ionizable Lipids
Kepan Chen, Na Fan, Hai Huang, et al.
Advanced Functional Materials (2022) Vol. 32, Iss. 39
Open Access | Times Cited: 67
Targetable elements in SARS-CoV-2 S2 subunit for the design of pan-coronavirus fusion inhibitors and vaccines
Liyan Guo, Sheng Lin, Zimin Chen, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 44
A truncated pre-F protein mRNA vaccine elicits an enhanced immune response and protection against respiratory syncytial virus
Min Lin, Yifan Yin, Xiaomeng Zhao, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Glycopeptide antibiotic teicoplanin inhibits cell entry of SARS-CoV-2 by suppressing the proteolytic activity of cathepsin L
Fei Yu, Ting Pan, Feng Huang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 122
Therapeutic targets and interventional strategies in COVID-19: mechanisms and clinical studies
Yuwen Zhou, Yao Xie, Liansha Tang, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 100
Ferritin nanoparticle-based SARS-CoV-2 RBD vaccine induces a persistent antibody response and long-term memory in mice
Wenjun Wang, Baoying Huang, Yanping Zhu, et al.
Cellular and Molecular Immunology (2021) Vol. 18, Iss. 3, pp. 749-751
Open Access | Times Cited: 84
A potent bispecific nanobody protects hACE2 mice against SARS-CoV-2 infection via intranasal administration
Xilin Wu, Lin Cheng, Ming Fu, et al.
Cell Reports (2021) Vol. 37, Iss. 3, pp. 109869-109869
Open Access | Times Cited: 81
Current and future nanoparticle vaccines for COVID-19
Mai N. Vu, Hannah G. Kelly, Stephen J. Kent, et al.
EBioMedicine (2021) Vol. 74, pp. 103699-103699
Open Access | Times Cited: 80
SARS-CoV-2 RBD-Tetanus Toxoid Conjugate Vaccine Induces a Strong Neutralizing Immunity in Preclinical Studies
Yury Valdés-Balbín, Darielys Santana-Mederos, Lauren Quintero, et al.
ACS Chemical Biology (2021) Vol. 16, Iss. 7, pp. 1223-1233
Open Access | Times Cited: 79
Nanotechnology-empowered vaccine delivery for enhancing CD8+ T cells-mediated cellular immunity
Liu Guang-na, Motao Zhu, Xiao Zhao, et al.
Advanced Drug Delivery Reviews (2021) Vol. 176, pp. 113889-113889
Closed Access | Times Cited: 78
Functionalizing Ferritin Nanoparticles for Vaccine Development
Margarida Q. Rodrigues, Paula M. Alves, António Roldão
Pharmaceutics (2021) Vol. 13, Iss. 10, pp. 1621-1621
Open Access | Times Cited: 77
Page 1 - Next Page

Scroll to top